Ultra early molecular biologic diagnosis of malignant and neurodegenerative diseases by the immunospecific profiles of the proteins markers of the surface of the mobilized autologous hematopoietic stem cells.

Abstract

The comparative study of the protein markers of the membrane surface of the autologous hematopoietic stem cells (СD34+ СD45+) was performed to detect the patterns of the proteomic profiles, if any. The study included five groups. The subpopulations of the hematopoietic stem cells were studied in 569 samples of the mobilized peripheral blood mononuclear cells from adult cancer cases (group 1), 557 samples from children cancer cases (group 2), 66 samples from amyotrophic lateral sclerosis cases (group 3), 5 samples from other neurodegenerative diseases cases (supplementary group 4) and 61 samples isolated from healthy donors (control group 5). The protein markers of the membrane surface of the autologous hematopoietic stem cells were mapped and profiled with flow cytometry. The specific patterns of the proteomic profiles characteristic for cancer and neurodegenerative disease and different from those of healthy donors were identified. The authors suppose that as far as the HSC is the parent cell of the immune system cells, the modification of its proteomic profile speaks of specific immune insufficiency that not only accompanies the disease but presents the key cause for its onset and precedes its clinical manifestation. Thus, the evaluation of the protein markers of the membrane surface of hematopoietic stem cells can be used for ultra early diagnosis of these diseases.